Keeping you up to date with reliable diabetes research, policy & guidance
What are the benefits of insulin pumps compared with multiple daily injections of insulin? This report by the US Agency for Healthcare Quality and Research summarises what the evidence says. Clinical question: In diabetics using insulin, does continuous subcutaneous insulin infusion (CSII), compared with multiple daily injections (MDI), improve quality of life or glycaemic control? The [read the full story…]
An appraisal of a 2010 systematic review of continuous subcutaneous insulin infusion (CSII, or insulin pumps) has been published in DARE. Research question: In diabetes, does CSII as compared with multiple daily injections (MDI), improve the clinical or cost-effectiveness of care? The review included both adults and children with type 1 or type 2 diabetes. [read the full story…]
This systematic review set out to establish the effectiveness and optimal delivery of educational interventions to help adults with type 1 diabetes who are using insulin pump therapy. Clinical question: In adults with type 1 diabetes using or starting insulin pump therapy, what is the effectiveness of educational interventions? The review included both patients starting [read the full story…]
Insulin pump therapy, or Continuous Subcutaneous Insulin Infusion (CSII), has many potential benefits for children with type 1 diabetes. This review set out to summarise the clinical effects compared with multiple daily injections (MDI) of insulin lispro. Clinical question: In children and adolescents with type 1 diabetes, how effective is delivery of insulin lispro by [read the full story…]
Clinical question In adults with type 1 diabetes starting insulin pump therapy, what is the best approach to education? The evidence The reviewers searched for published research between 1998 and 2008. They found five studies, with widely varying methods and outcome measures. No overall conclusion could be drawn from the findings. Appraisal hints Users of [read the full story…]
The STAR trial investigated the benefits of sensor-augmented pump therapy compared with multiple daily injections (MDI) in adults with type 1 diabetes. This report of results from the trial tries to identify features of the patients who were more likely to experience improved glycaemic control in both group. This might help us to identify patients [read the full story…]
